MEIJI YASUDA ASSET MANAGEMENT CO LTD. – Regeneron Pharmaceuticals, Inc. Transaction History
MEIJI YASUDA ASSET MANAGEMENT CO LTD. portfolio value:
$4.16M
portfolio value
MEIJI YASUDA ASSET MANAGEMENT CO LTD. quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -4.73% | -300 shares | 413K | $688.87 | 6.04K |
| Q2 2022 | share | Decrease | -21.92% | -1.78K shares | -1.92M | $591.13 | 6.34K |
| Q1 2022 | share | Decrease | -2.84% | -237 shares | 393K | $698.42 | 8.12K |
| Q4 2021 | share | Increase | +2.30% | 188 shares | 334K | $642.51 | 8.35K |
| Q3 2021 | share | Decrease | -2.99% | -252 shares | 241K | $605.18 | 8.16K |
| Q2 2021 | share | Increase | +0.48% | 40 shares | 738K | $558.54 | 8.42K |
| Q1 2021 | share | Increase | +7.30% | 570 shares | 191K | $473.14 | 8.38K |
| Q4 2020 | share | Increase | +19.86% | 1.29K shares | 126K | $483.11 | 7.81K |
| Q3 2020 | share | Decrease | -10.69% | -780 shares | -903K | $559.78 | 6.51K |
| Q2 2020 | share | Increase | +394.04% | 5.82K shares | 3.83M | $623.65 | 7.29K |
| Q1 2020 | share | Decrease | -35.13% | -800 shares | -134K | $488.29 | 1.47K |
| Q4 2019 | share | Increase | +14.59% | 290 shares | 304K | $375.48 | 2.27K |
| Q3 2019 | share | Decrease | -4.79% | -100 shares | -102K | $277.4 | 1.98K |
| Q2 2019 | share | Decrease | -26.62% | -757 shares | -515K | $313 | 2.08K |
| Q1 2019 | share | Decrease | -0.70% | -20 shares | 98K | $410.62 | 2.84K |
| Q4 2018 | share | Decrease | -0.45% | -13 shares | -92K | $373.5 | 2.86K |
| Q3 2018 | share | Increase | +61.90% | 1.1K shares | 549K | $404.04 | 2.87K |
| Q2 2018 | share | 0.00% | 0 shares | 1K | $344.99 | 1.77K | |
| Q1 2018 | share | Increase | +5.96% | 100 shares | -18K | $344.36 | 1.77K |
| Q4 2017 | share | Decrease | -15.17% | -300 shares | -254K | $375.96 | 1.67K |
| Q3 2017 | share | Increase | +17.89% | 300 shares | 60K | $447.12 | 1.97K |
| Q2 2017 | share | 0.00% | 0 shares | 174K | $491.14 | 1.67K | |
| Q1 2017 | share | Decrease | -15.17% | -300 shares | -76K | $387.51 | 1.67K |
| Q4 2016 | share | Increase | +51.84% | 675 shares | 203K | $367.09 | 1.97K |
| Q3 2016 | share | Decrease | -20.22% | -330 shares | -47K | $402.02 | 1.30K |
| Q2 2016 | share | Increase | +91.55% | 780 shares | 263K | $349.23 | 1.63K |
| Q1 2016 | share | Increase | +1.19% | 10 shares | -150K | $360.44 | 852 |